Skip to main content

Table 2 Clinical characteristics of study population

From: Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey

Variables

No. of patients

n(%)

Western medicine

n(%)

Chinese medicine n(%)

P-value

Total

786(100.0)

337(42.9)

449(57.1)

Cancer type

< 0.001

Lung

145(18.4)

46(13.6)

99(22.0)

Breast

128(16.3)

50(14.8)

78(17.4)

Prostate

22(2.8)

11(3.3)

11(2.4)

Colorectal

114(14.5)

53(15.7)

61(13.6)

Liver

13(1.7)

1(0.3)

12(2.7)

Stomach

15(1.9)

4(1.2)

11(2.4)

Nasopharyngeal

117(14.9)

45(13.4)

72(16.0)

Cervical

17(2.2)

12(3.6)

5(1.1)

Endometrial

23(2.9)

13(3.9)

10(2.2)

Ovary

18(2.3)

12(3.6)

6(1.3)

Other

174(22.1)

90(26.7)

84(18.7)

Stage (TNM)

< 0.001

0-I

106(13.5)

56(16.6)

50(11.1)

II

122(15.5)

49(14.5)

73(16.3)

III

202(25.7)

71(21.1)

131(29.2)

IV

116(14.8)

35(10.4)

81(18.0)

Unknown

240(30.5)

126(37.5)

114(25.4)

Time since diagnosis (months)

0.005

36

537(68.3)

216(64.1)

321(71.5)

>36, 48

59(7.5)

23(6.8)

36(8.0)

>48, <60

27(3.4)

9(2.7)

18(4.0)

60

153(19.5)

81(24.0)

72(16.0)

Unknown

10(1.3)

8(2.4)

2(0.4)

  1. Data are presented as the actual number of patients (percentage in that group). Chi-square tests were conducted between Western medicine and Chinese medicine users.